Recruiting NA INTERVENTIONAL 3-arm NCT06414941

The Effect of Dexmedetomidine and Esketamine Combined Infusion Quality of Sleep Undergoing Modified Radical Mastectomy

Dexmedetomidine Combined With Esketamine Effects the Quality of Sleep

Sponsor: Anqing Municipal Hospital

Conditions Dexmedetomidine Plus Esketamine Affect Postoperative Sleep Quality

Interventions Dexmedetomidine administration Dexmedetomidine plus high-dose esketamine administration Dexmedetomidine plus low-dose esketamine administration

Updated 3 times since 2024 Last updated: May 10, 2024 Started: May 15, 2024 Primary completion: Oct 10, 2024 Completion: Oct 20, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06414941, this NA trial focuses on Dexmedetomidine Plus Esketamine Affect Postoperative Sleep Quality and remains actively recruiting participants. Sponsored by Anqing Municipal Hospital, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Recruiting NA

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anqing Municipal Hospital

Data source: Anqing Municipal Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Anqing, China